|Bid||10.20 x 900|
|Ask||10.21 x 800|
|Day's Range||10.20 - 10.24|
|52 Week Range||9.57 - 10.25|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
New Frontier Data , the authority in data, analytics and business intelligence for the global cannabis industry, releases a new study in partnership with Humboldt Green, Sunboldt Grown, and Ice Box Flat ...
Among the public health concerns commonly cited by opponents of cannabis legalization is a perceived increase in traffic accidents and fatalities. This has not been the case," explained Dr Reggie Gaudino, New Frontier Data's Chief Science Adviser. Research from the American Journal of Public Health set out to evaluate fatalities as a result of vehicle crashes in Washington state and Colorado (the first U.S. states to introduce full cannabis legalization), while comparing them to similar states without legalized cannabis for adult use.
Q: With more conversations about national reforms being had in Washington, D.C., what was the takeaway from your new report regarding the nationwide forecast for jobs and taxes pending federal legalization? A: In gathering the research presented in New Frontier Data's recent release, Cannabis in the U.S. Economy: Jobs, Growth and Tax Revenue (2019 Edition), projections were based on the current economic impacts shaping the federal tax revenues and jobs associated with the legal cannabis market as it currently exists. In the current legal structure, there are approximately 340,000 jobs (direct and indirect, but not induced) associated with the cannabis industry.
The cannabis-focused analytics company, New Frontier Data , announced an agreement Wednesday to acquire Zefyr, Inc ., a data discovery and profiling platform serving the cannabis industry. Zefyr collects data ...
The Netherlands has long been known for entertaining a progressive stance towards cannabis distribution and adult use. Since the 1970s, the country's cannabis "coffeeshops" have been tolerated throughout various regimes as a means to separate cannabis from harder drugs, and create a relatively safe environment for people to purchase and consume cannabis products. Such a disconnect lacks accountability for quality or consistency, due to the illicit-market supply chain for coffeeshops to obtain its stocks in the first place.
As public support for reform surges and the U.S. legal cannabis industry continues to mature, New Frontier Data has been tracking the impact which legalization has had on both jobs and taxes in each legal state across the nation. The results – and forecasts informed by them – are now available in the 2019 edition of Cannabis in the U.S. Economy: Jobs, Growth & Tax Revenue. With 11 states allowing adult-use access to cannabis, and 33 states permitting medical access, more than 68% of the U.S. population has access to legal cannabis in some form.
Q: With headlines about retailers detailing their general demise, what are the market prospects for cannabis outlets and dispensaries? A: While it is true that prospects seem bleak for the local mall and businesses from Forever 21 to J.C. Penney (NYSE: JCP) and J. Crew, retail is not dead. According to the most recently available figures from the U.S. Census Bureau, estimates of U.S. retail and food services sales for August 2019 (adjusted for seasonal variation and holiday and trading-day differences, but not price changes) increased 0.4% from the previous month, and 4.1% year-over-year above August 2018.
Analysis of data generated from the U.S. market gives Europe the advantage of having a roadmap for the dynamic new markets. Some takeaways from New Frontier Data's recent release, "The U.S. Cannabis Report: 2019 Industry Outlook", offers European countries some ideas about what a cannabis-infused future may look like. Changes in public attitudes and perceptions toward cannabis are already taking hold in Europe.
An often underappreciated fact about the now bustling cannabis market is that the first entirely legal, adult-use, retail sale of marijuana in the world happened just about five years ago, and it happened in Colorado. With the release of its 2019 U.S. Cannabis Report, industry analyst firm New Frontier data takes a closer look at the evolution of the world’s first legal cannabis market over its initial five years of operation.
The report examines the current state of hemp cultivation in the United States. "The 29 U.S. states reporting licensed hemp cultivation acreage total almost half a million acres in combined cultivation land area, which is a massive increase compared to 2018 figures of a total land area barely over 100,000 acres. While there continues to be uncertainty and a healthy amount of confusion around hemp cultivation for CBD production, it is clear that demand is nonetheless continuing to rise across the U.S.," noted Giadha Aguirre de Carcer, New Frontier Data CEO and Founder.
Q: Given some persistent headlines about Oregon's chronic oversupply in cannabis production, what are the prospects for the 2019 harvest season there? A: According to a forecast prepared by New Frontier Data's Senior Economist Beau Whitney, another significant harvest is predicted for Oregon this season. "On average, this year's harvest will not be close to the record harvest of 2017 on a per-license basis, but will be higher than last year's output," Whitney explained.
Since federal passage of the 2018 Farm Bill last December, interest in hemp farming has catalyzed a national industry reborn after decades of prohibition. Reports from state agriculture officials indicate that licensed hemp acreage for 2019 has more than tripled, with the number of hemp licenses issued having quadrupled since 2018. It is increasingly likely that the U.S. hemp industry will see more acreage planted this year than in 1943, the peak of cultivation during World War II.
Vaping products, one of the fastest-growing segments of the legal marijuana industry, have taken a hit from consumers as public health experts scramble to determine what’s causing a mysterious and sometimes fatal lung disease among people who use e-cigarettes. Some vaped nicotine, but many reported using oil containing THC, marijuana’s high-inducing ingredient, and said they bought products from pop-up shops and other illegal sellers. The only death linked to THC vapes bought at legal shops occurred in Oregon.
The United States cannabis market was worth an estimated $74.6 billion over the course of 2018 according to the recently released 2019 U.S. Cannabis Report. The report shows that the legal cannabis market has grown substantially over the past few years thanks to a growing medical or recreational market that, as of 2019, encompasses 33 states and the District of Columbia.
Altitude Investment Management announced its first investment in the European cannabis market Monday, providing $5.5 million to Switzerland-based KannaSwiss AG. KannaSwiss AG is known as the leading supplier of top-tier CBD isolate products in Europe, the company said. "My partners and I have been laser-focused on investing in the legal cannabis industry since 2016.
Throughout the past month, the vaping sector has been shaken by the sudden emergence of a mysterious lung illness related to the use of e-cigarettes or vape pens, with hundreds of illnesses diagnosed and eight reported deaths to date. "I'd say we are looking for something more recently introduced, or it's something that was present but is now being misused by newer entries into the market that are less knowledgeable," he said.
New Frontier Data, the global authority in data, analytics and business intelligence for the cannabis industry, in partnership with Global Cannabinoids, a leading producer, manufacturer and distributor of American-Grown Hemp-Derived Cannabinoids in the U.S., releases The U.S. Cannabis Report 2019 Industry Outlook. The report examines U.S. cannabis industry forecasts and trends, including industry revenue projections, illicit market sizing, cannabis consumer behavior, and potential interaction with the opioids market in the U.S.
Elliott Smith, Partner at Winston & Strawn LLP Successful SPACs need transaction advisors with SPAC deal-making experience. Often the best acquisition targets are growth companies rather than distressed assets. And while some SPAC IPOs have approached a billion dollars, huge SPACs can encounter challenges in finding a viable target that’s appropriate in size. That’s according […]
Last week, Altria Group and Philip Morris International (PMI) announced being in discussions for a potential all-stock “merger of equals,” signifying a combined $210 billion deal with impacts for one of the Canadian cannabis sector’s leading companies. Some investors have been initially tepid about the deal to create a new tobacco titan, that said the question for cannabis stakeholders is whether this massive transaction is in fact about tobacco. Altria and PMI have both invested in researching reduced-risk products (RRPs), including e-cigarettes and PMI’s IQOS products, to offset declining sales in the traditional smokable tobacco space.
As a new wave of states from Illinois to Missouri face their advent of newly legal cannabis, New Frontier Data's analysis of Colorado's first years of legal cannabis offers insights about the country's most established adult-use market, as a guide for expectations as mores states adopt policy reforms. When given a (good) choice, consumers will go legal. With over $6 billion in sales throughout its market's first five years (2014-2018), consumers have flocked to Colorado, attracted by competitive prices, expansive options of regulated products, and widespread access in major population centers.
A: Though we have seen considerable growth and increased legitimacy in the legal cannabis industry, many ancillary businesses are still trying to find their way. Last month, New Frontier Data and CohnReznick attended an Appraisal Institute Conference in Denver (July 23-24) to discuss cannabis-related opportunities in the appraisal industry. In the emerging cannabis markets, there is a lot of speculation about land purchases, warehouse rentals, and business valuations.
For the first time in five years of Colorado's coexisting, legalized adult-use and medical cannabis markets, recreational sales more than doubled medical sales in 2018, according to state regulators' figures. Colorado rolled out its adult-use market in 2014, after beginning its medical program in 2000. The differentiation has occurred as the Centennial State's longer-matured medical market has seen a general plateau in sales, while its adult-use market's sales continue to climb.
Each member state in the European Union has their own distinct health systems. Combine that with the fact they all have their own laws regarding cannabis cultivation and distribution, the result is a smorgasbord of medical cannabis approaches. By simply comparing the latest news from the four biggest potential markets, we get a glimpse of how complex the European medical cannabis situation is and how varied the level of progress has been across the continent.
Q: On your website , you refer to helping policymakers as well as investors and other industry stakeholders. What is an example of your involvement with government authorities? A: Instances of how ...
A Florida court of appeals decision last month ruled that the state's regulatory framework for its medical cannabis program mandating vertical integration was unconstitutional. What does it mean for Florida's system, or for other states? Florida's blueprint for vertical integration had been an obvious bulwark against unlimited licensure, but the court essentially deemed it to be an overcorrection.